Testicular Neoplasms

• 

  Subject Areas on Research

  • A 5-year followup study of asymptomatic men with testicular microlithiasis. 
  • A granuloma of the testis of unknown etiology. 
  • A reappraisal of the results of stopping therapy in childhood leukemia. 
  • ACR Appropriateness Criteria Staging of Testicular Malignancy. 
  • ATM activation in normal human tissues and testicular cancer. 
  • Active chemotherapy for metastatic stromal cell tumor of the testis. 
  • Adult testicular sarcoma: presentation, evaluation, and treatment. 
  • Antigens shared by rat schwannomas, neuroblastomas, and a testicular interstitial cell carcinoma. 
  • Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. 
  • BAX-mediated cell death affects early germ cell loss and incidence of testicular teratomas in Dnd1(Ter/Ter) mice. 
  • Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors. 
  • Cancer risk in men exposed in utero to diethylstilbestrol. 
  • Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization. 
  • Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer. 
  • Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. 
  • Clinically occult Leydig cell tumor presenting with gynecomastia. 
  • Complications of therapy for testicular cancer. 
  • Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? 
  • Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery. 
  • DNA ploidy in nonseminomatous germ cell testicular tumor. 
  • Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. 
  • Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization. 
  • Development and characterization of a monoclonal antibody to human embryonal carcinoma. 
  • Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. 
  • Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. 
  • Efficacy of radiographic chest imaging in patients with testicular cancer. 
  • Epididymal leiomyoma: sonographic features. 
  • Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas. 
  • Fasciitis ossificans with a radial neuropathy: a benign differential diagnosis for soft tissue sarcoma. 
  • Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors. 
  • Genotypic divergence precedes clinical dissemination in a case of synchronous bilateral B-cell malignant lymphoma of the testes. 
  • Growing Teratoma Syndrome of Testicular Origin. 
  • Gynaecomastia and extragonadal symptoms leading to diagnosis delay of germ cell tumours in young men. 
  • HIV infection presenting as an unusually large pure yolk sac tumor of the testis. 
  • Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. 
  • Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours. 
  • Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors. 
  • Inappropriate surgery for testicular cancer. 
  • Increased evidence of testicular cancer among veterans of the 1991 Gulf War. 
  • Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. 
  • Isolation of a human teratoma cell line which expresses F9 antigen. 
  • Laparoscopic removal of gonads containing on occult seminoma in a woman with complete androgen resistance. 
  • Management of extraretroperitoneal masses in germ cell tumor. 
  • Mesothelioma of the tunica vaginalis testis. 
  • Metastatic ampullary adenocarcinoma presenting as a hydrocele: a case report. 
  • Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. 
  • Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors. 
  • Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer. 
  • New tumor markers of testis cancer. 
  • Non functioning interstitial cell carcinoma of testis. 
  • Nongenital granuloma inguinale in an oncology patient. 
  • Novel retrotransposed imprinted locus identified at human 6p25. 
  • Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo. 
  • Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. 
  • Partial orchiectomy for bilateral synchronous testicular masses in a prepubescent boy: a case report. 
  • Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. 
  • Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score. 
  • Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. 
  • Primary testicular lymphoma: the site matters. 
  • Primary testicular natural killer/T-cell lymphoma: A CARE-case report and review of literature. 
  • Prognostic factors in low-stage nonseminomatous testicular cancer. 
  • Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease. 
  • Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease. 
  • Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. 
  • Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis. 
  • Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors. 
  • Proper staging techniques in testicular cancer patients. 
  • Re: Review of delayed orchiectomy in patients with disseminated testis tumors. 
  • Refusal in testicular cancer patients: implications for surveillance. 
  • Refusal of cancer treatment in testicular cancer patients. 
  • Response to antiangiogenesis therapy in a patient with advanced adult-type testicular granulosa cell tumor. 
  • Retroaortic left renal vein in testicular cancer patient: potential staging and treatment pitfall. 
  • Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma. 
  • Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. 
  • Retroperitoneal lymphadenectomy. 
  • Risk factors for cancer of the testis. 
  • Robot-Assisted Retroperitoneal Lymphadenectomy in Testicular Cancer Treatment: A Systematic Review. 
  • Seminoma Metastatic to the Orbit. 
  • Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study. 
  • Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist. 
  • Sonography of an intratesticular lipoma. 
  • Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. 
  • Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases. 
  • Synchronous bilateral testicular tumour: nonseminomatous germ cell tumours and contralateral benign tumours. 
  • Synchronous bilateral testis tumor: mixed germ cell and theca cell tumors. 
  • Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Testicular cancer and Persian Gulf War service. 
  • Testicular cancer in blacks. A multicenter experience. 
  • Testicular cancer survivorship: research strategies and recommendations. 
  • Testicular cancer. Clinical practice guidelines in oncology. 
  • Testicular cancer. Clinical practice guidelines. 
  • Testicular carcinoma. 
  • Testicular microlithiasis and subsequent development of metastatic germ cell tumor. 
  • Testicular teratomas: an intersection of pluripotency, differentiation and cancer biology. 
  • Testicular tumour. 
  • The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. 
  • The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. 
  • The cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. 
  • The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study. 
  • The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation. 
  • The natural progression of adenocarcinoma of the epididymis. 
  • The prevalence of testicular microlithiasis in an asymptomatic population of men 18 to 35 years old. 
  • The role of retroperitoneal lymphadenectomy in mature teratoma of the testis. 
  • Thymic hyperplasia in newly diagnosed testicular germ cell tumors. 
  • Timely diagnosis of testicular cancer. 
  • Unnecessary mastectomy for gynecomastia in testicular cancer patient. 
  • Urologic surgery. 
  • Well-differentiated papillary mesothelioma. 
  • [Variation of mortality risk among cancer patients and individualized therapy]. 
• 

  Keywords of People

  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics